Table 4.
Analysis of risk factors for the complications in patients who underwent FNA of the pancreas
With complications | Without complications | P valuea | |
---|---|---|---|
n = 11 | n = 316 | ||
Age | 71.0 ± 9.6 | 66.1 ± 11.4 | 0.163b |
Sex | |||
M:F | 7:4 | 171:145 | 0.760 |
Location | |||
Head | 6 | 129 | 0.371 |
Body/tail | 5 | 187 | |
Tumor size (mm) | |||
≤20 >20 |
3 8 |
268 48 |
<0.001 |
Benign | 1 | 34 | 0.012c |
PNETs | 3 | 11 | |
Other tumors (PK, sarcoma, SPN) | 7 | 271 | |
Site of needle pass | |||
Stomach | 5 | 193 | 0.353 |
Duodenum | 6 | 123 | |
Needle size (gauge) | |||
25 | 0 | 28 | 0.263d |
22 | 9 | 259 | |
19 | 2 | 29 | |
Number of needle passes | |||
<2 >3 |
2 9 |
156 160 |
0.063 |
Needle pass via the normal pancreas | |||
Yes | 8 | 143 | 0.121 |
No | 3 | 173 | |
Length of the needle penetration | |||
Absence | 3 | 173 | 0.048d |
<1 cm | 4 | 89 | |
1–2 cm | 3 | 43 | |
>2 cm | 1 | 11 |
aFisher’s exact test
b t test
c P values for paired comparisons are as follows: P = 0.065 for benign versus PNETs, P = 1.000 for benign versus other tumor, and P = 0.009 for PNETs versus tumor
dChi-square test for trend